Short-Term Lamivudine for the Treatment of Chronic Hepatitis B

Publisher： Karger

E-ISSN： 1423-0100|46|6|367-372

ISSN： 0300-5526

Source： Intervirology, Vol.46, Iss.6, 2003-12, pp. : 367-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short-Term Lamivudine Therapy in Patients with Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 362-366

Karger

Access to resources Recommend Favorite

Cirrhosis regression by lamivudine

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 372-378

John Wiley & Sons Inc

Access to resources Recommend Favorite

Virological and Biochemical Relapse after Discontinuation of Lamivudine Monotherapy for Chronic Hepatitis B in Japan: Comparison with Breakthrough Hepatitis during Long-Term Treatment

By  

Intervirology, Vol. 48, Iss. 2-3, 2005-03 ,pp. : 174-182

Karger

Access to resources Recommend Favorite

Polymerase Domain B Mutation Is Associated with Hepatitis Relapse during Long-Term Lamivudine Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 48, Iss. 6, 2005-07 ,pp. : 381-388

Karger

Access to resources Recommend Favorite

Continued Lamivudine Therapy in Patients with Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 377-387

Karger

Access to resources Recommend Favorite